IPNA develops and endorses evidence-based clinical practice recommendations for the diagnosis and management of kidney diseases in children and young people. Its guidance is designed for international relevance and supports best practice in paediatric nephrology.
Direct Link: IPNA Guidelines
• Population: Children and young people.
• Scope: Paediatric kidney disease, including glomerular disease, nephrotic syndrome, inherited and rare kidney conditions, and other childhood nephrology topics.
• Document Types: IPNA-prepared guidelines, endorsed guidelines, and regional guidance.
• Clinical Focus: Diagnosis, risk assessment, treatment, monitoring, and family-centred care.
Key Resource: Steroid-Sensitive Nephrotic Syndrome
IPNA Clinical Practice Recommendations for the Diagnosis and Management of Children with Steroid-Sensitive Nephrotic Syndrome
• Publication Year: 2022
• Key Topics: Diagnostic evaluation, corticosteroid-sensitive disease, relapse management, treatment complications, vaccination, and family education.
• Resource Access: Refer to the IPNA Guidelines link above for the original guideline and supporting materials.
Key Resource: Steroid-Resistant Nephrotic Syndrome
IPNA Clinical Practice Recommendations for Steroid-Resistant Nephrotic Syndrome
• Key Topics: Evaluation, genetic testing, supportive care, immunosuppressive treatment, and long-term monitoring.
• Resource Access: Refer to the IPNA Guidelines link above for the original guidance.
• Kidney Hub Link Check: 21 August 2026. Always consult the full original source and apply guidance in the context of the child’s clinical circumstances, local pathways, and specialist paediatric-nephrology input.